Guardant Health, Inc. (GH) Operating Income (Loss) USD 2017 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Guardant Health, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2024.
Guardant Health, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$99.7 M, a 25.6% increase year-over-year.
Guardant Health, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$530 M, a 4.46% increase year-over-year.
Guardant Health, Inc. annual Operating Income (Loss) for 2023 was -$565 M, a 3.74% decline from 2022.
Guardant Health, Inc. annual Operating Income (Loss) for 2022 was -$544 M, a 32.5% decline from 2021.
Guardant Health, Inc. annual Operating Income (Loss) for 2021 was -$411 M, a 61.2% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	-$530 M	-$99.7 M	+$34.4 M	+25.6%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	-$565 M	-$198 M	-$51.4 M	-35.2%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-22
Q3 2023	-$513 M	-$114 M	+$31.1 M	+21.5%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-06
Q2 2023	-$544 M	-$120 M	+$10.7 M	+8.21%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	-$555 M	-$134 M	-$10.7 M	-8.69%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	-$544 M	-$146 M	-$47.9 M	-48.8%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-22
Q3 2022	-$496 M	-$145 M	-$37.3 M	-34.8%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-06
Q2 2022	-$459 M	-$130 M	-$32.7 M	-33.5%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	-$426 M	-$123 M	-$15.5 M	-14.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q4 2021	-$411 M	-$98.2 M	-$7.04 M	-7.72%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-22
Q3 2021	-$404 M	-$107 M	-$33 M	-44.5%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	-$371 M	-$97.6 M	-$43 M	-78.8%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	-$328 M	-$108 M	-$73 M	-209%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	-$255 M	-$91.2 M	-$65.2 M	-251%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-23
Q3 2020	-$190 M	-$74.3 M	-$56.8 M	-325%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	-$133 M	-$54.6 M	-$39.4 M	-258%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	-$93.6 M	-$34.9 M	-$11.2 M	-47.5%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	-$82.4 M	-$26 M	+$1.43 M	+5.2%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-24
Q3 2019	-$83.8 M	-$17.5 M	+$6.73 M	+27.8%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	-$90.5 M	-$15.3 M	+$7.44 M	+32.7%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	-$98 M	-$23.7 M	-$5.02 M	-26.9%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	-$92.9 M	-$27.4 M			Oct 1, 2018	Dec 31, 2018	10-K	2021-02-25
Q3 2018		-$24.2 M	+$4.47 M	+15.6%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018		-$22.7 M			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-07
Q1 2018		-$18.6 M			Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-10
Q3 2017		-$28.7 M			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-19

* An asterisk sign (*) next to the value indicates that the value is likely invalid.